Rubric Capital Management LP's Trading History
| HRTXHeron Therapeutics | Oct 17, 2025 | Ten Percent Owner | Uninformative Buy | ― | $8.86M | |
| COLLCollegium Pharmaceutical | Aug 15, 2025 | Ten Percent Owner | Informative Sell | 946.25K | $74.18M | |
| TLNTalen Energy Corp | Jun 27, 2025 | Ten Percent Owner | Uninformative Sell | ― | $1.50B | |
| TXMDTherapeuticsMD | Nov 17, 2023 | Director, See Remarks., Ten Percent Owner | Uninformative Buy | 2.00M | $5.33M | |
| ~RDUSRadius Health | Aug 12, 2022 | ― | Informative Buy | 16.91M | $87.11M | |
| MREOMereo Biopharma Group Plc | ― | Ten Percent Owner | ― | ― |
You May Also Like
Rubric Capital Management LP insider profile FAQ
What is the percentage of profitable transactions made by Rubric Capital Management LP?
The percentage of profitable transactions made by Rubric Capital Management LP is 27%.
What is the average return per transaction made by Rubric Capital Management LP?
The average return per transaction made by Rubric Capital Management LP is -12.70%.
What stocks does Rubric Capital Management LP hold?
Rubric Capital Management LP holds: HRTX, TXMD, ~RDUS, COLL, MREO, TLN stocks.
What was Rubric Capital Management LP's most profitable transaction?
Rubric Capital Management LP’s most profitable transaction was an Informative Sell of TXMD stock on January 3, 2023. The return on the trade was 63.20%.
What is Rubric Capital Management LP's role in Heron Therapeutics?
Rubric Capital Management LP's role in Heron Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.